0001193125-24-072046.txt : 20240320 0001193125-24-072046.hdr.sgml : 20240320 20240320071031 ACCESSION NUMBER: 0001193125-24-072046 CONFORMED SUBMISSION TYPE: 8-K PUBLIC DOCUMENT COUNT: 14 CONFORMED PERIOD OF REPORT: 20240317 ITEM INFORMATION: Cost Associated with Exit or Disposal Activities ITEM INFORMATION: Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers ITEM INFORMATION: Regulation FD Disclosure ITEM INFORMATION: Financial Statements and Exhibits FILED AS OF DATE: 20240320 DATE AS OF CHANGE: 20240320 FILER: COMPANY DATA: COMPANY CONFORMED NAME: HERBALIFE LTD. CENTRAL INDEX KEY: 0001180262 STANDARD INDUSTRIAL CLASSIFICATION: WHOLESALE-DRUGS PROPRIETARIES & DRUGGISTS' SUNDRIES [5122] ORGANIZATION NAME: 07 Trade & Services IRS NUMBER: 000000000 STATE OF INCORPORATION: E9 FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: 8-K SEC ACT: 1934 Act SEC FILE NUMBER: 001-32381 FILM NUMBER: 24766268 BUSINESS ADDRESS: STREET 1: P.O. BOX 309GT STREET 2: UGLAND HOUSE, SOUTH CHURCH STREET CITY: GEORGE TOWN STATE: E9 ZIP: 00000 BUSINESS PHONE: 310 410 9600 MAIL ADDRESS: STREET 1: P.O. BOX 309GT STREET 2: UGLAND HOUSE, SOUTH CHURCH STREET CITY: GEORGE TOWN STATE: E9 ZIP: 00000 FORMER COMPANY: FORMER CONFORMED NAME: HERBALIFE NUTRITION LTD. DATE OF NAME CHANGE: 20180424 FORMER COMPANY: FORMER CONFORMED NAME: HERBALIFE LTD. DATE OF NAME CHANGE: 20041214 FORMER COMPANY: FORMER CONFORMED NAME: WH HOLDINGS CAYMAN ISLANDS LTD DATE OF NAME CHANGE: 20020814 8-K 1 d809540d8k.htm 8-K 8-K
false 0001180262 0001180262 2024-03-17 2024-03-17

 

 

UNITED STATES

SECURITIES AND EXCHANGE COMMISSION

WASHINGTON, D.C. 20549

 

 

FORM 8-K

 

 

CURRENT REPORT

Pursuant to Section 13 or 15(d)

of the Securities Exchange Act of 1934

Date of report (Date of earliest event reported): March 17, 2024

 

 

Herbalife Ltd.

(Exact Name of Registrant as Specified in Charter)

 

 

 

Cayman Islands   1-32381   98-0377871

(State or Other Jurisdiction

of Incorporation)

  

(Commission

File Number)

  

(IRS Employer

Identification No.)

 

P.O. Box 309, Ugland House,

Grand Cayman

Cayman Islands

   KY1-1104
(Address of Principal Executive Offices)   (Zip Code)

Registrant’s telephone number, including area code: c/o (213) 745-0500

Not Applicable

(Former Name or Former Address, if Changed Since Last Report)

 

 

Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions:

 

☐

Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)

 

☐

Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)

 

☐

Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))

 

☐

Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))

Securities registered pursuant to Section 12(b) of the Act:

 

Title of each class

  

Trading
Symbol(s)

  

Name of each exchange

on which registered

Common Shares, par value $0.0005 per share   HLF   New York Stock Exchange

Indicate by check mark whether the registrant is an emerging growth company as defined in Rule 405 of the Securities Act of 1933 (§ 230.405 of this chapter) or Rule 12b-2 of the Securities Exchange Act of 1934 (§ 240.12b-2 of this chapter).

Emerging growth company ☐

If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act. ☐

 

 

 

Item 2.05 Costs Associated with Exit or Disposal Activities.

On March 17, 2024, the Board of Directors of Herbalife Ltd. (the “Company”) approved an internal restructuring plan designed to bring leadership closer to the Company’s markets and to accelerate productivity. The Company intends to implement actions throughout 2024 to streamline its employee structure. The Company expects to recognize at least $60 million of pre-tax expenses in 2024 related to the restructuring, which is primarily related to severance costs.

Item 5.02. Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers.

On March 17, 2024, Alex Amezquita ceased to serve as the Company’s Chief Financial Officer but will continue to serve as an employee of the Company.

On March 17, 2024, John DeSimone was appointed as the Company’s Chief Financial Officer.

Mr. DeSimone, 57, has served as a Special Advisor to the CEO since August 2023. Mr. DeSimone previously served as the Company’s Chief Strategic Officer from February 2023 until August 2023 and the Company’s Executive Vice Chairman from August 2022 until February 2023. Mr. DeSimone also served as the Company’s President from March 2020 until August 2022 and the Company’s Co-President and Chief Strategic Officer from May 2018 until March 2020. Previous to such roles, Mr. DeSimone served as the Company’s Chief Financial Officer from January 2010 until May 2018. Mr. DeSimone joined the Company in November 2007 as Senior Vice President, Corporate Financial Planning and Analysis and was promoted to the position of Senior Vice President, Finance & Distributor Operations in January 2009. Mr. DeSimone received his Bachelor of Science in Business Administration from Bryant College (now known as Bryant University).

Item 7.01 Regulation FD Disclosure.

On March 20, 2024, the Company issued a press release announcing certain information regarding guidance for first quarter and full-year 2024 results, as well as the restructuring and change in Chief Financial Officer discussed above, a copy of which is furnished as Exhibit 99.1 hereto and incorporated herein by reference.

The information contained in this Item 7.01 and Exhibit 99.1 attached to this report shall not be deemed “filed” for purposes of Section 18 of the Securities Exchange Act of 1934, as amended (the “Exchange Act”), or otherwise subject to the liabilities of that section and shall not be deemed incorporated by reference into any filing under the Securities Act of 1933, as amended (the “Securities Act”), or the Exchange Act, except as shall be expressly set forth by specific reference in such a filing.

Item 9.01. Financial Statements and Exhibits.

(d) Exhibits.

 

99.1    Press Release issued by Herbalife Ltd. on March 20, 2024.
104    Cover Page Interactive Data File (embedded within the Inline XBRL document).

 

SIGNATURES

Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.

 

  Herbalife Ltd.
March 20, 2024   By:  

/s/ HENRY C. WANG

    Name:   Henry C. Wang
    Title:   EVP, General Counsel and Corporate Secretary
 EX-99.1 2 d809540dex991.htm EX-99.1 EX-99.1

Exhibit 99.1

Herbalife Announces CFO Transition Initiates Guidance for First Quarter and Full-Year

2024

LOS ANGELES, March 20, 2024 – Herbalife Ltd. (NYSE: HLF), a premier health and wellness company, community and platform, today announced the appointment of John DeSimone as Chief Financial Officer, succeeding Alex Amezquita who will remain with the Company. Mr. DeSimone has been an executive at Herbalife for the past 17 years, including more than 8 years as CFO from 2010 – 2018 and 4 years as President and Co-President from 2018 – 2022. Most recently, he served as a Special Advisor to the CEO.

“John is a talented and proven finance leader, who has immense experience with Herbalife and a successful track record,” said Michael Johnson, Chairman and Chief Executive Officer. “We believe with Stephan Gratziani as President driving top-line growth and John focusing on our commitment to expand margins, reduce debt and improve overall financial performance, we are well-positioned to return to growth and maximize shareholder value in both the near and long term.”

In addition, management is beginning to observe more stability in the business. Based on this and other positive trends observed, Herbalife is initiating guidance for the first quarter and full-year 2024.

First Quarter and Full-Year 2024 Guidance

 

 $ million    Q1 ‘24 Guidance    Q1 ‘23 Results    FY ‘24 Guidance    FY ‘23 Results
         

 Net Sales

    1% – 3% y-o-y     1,252.1     0% – 5% y-o-y     5,062.4 

 Adjusted EBITDA1

    115 – 130     128.9     540 – 580     570.6 

 Capital Expenditures

    30 – 40     30.3     125 – 175     135.0 

Included in the full-year 2024 guidance is approximately $40 million of savings from a new organizational redesign project the Company began reviewing in January 2024. This project, which is separate from Herbalife’s Transformation Program, will bring leadership closer to the markets, streamline the organization and accelerate productivity. The Company expects to deliver at least $80 million of run rate savings from this project beginning in 2025. The Company also expects to recognize at least $60 million of pre-tax expenses in 2024 related to this restructuring, which will be excluded from the adjusted results.

“I’m honored to return to my role as CFO,” said John DeSimone, Chief Financial Officer. “I’m excited to leverage my experience and knowledge of Herbalife to improve our financial and operating performance, reduce our gross leverage ratio to 3.0x by the end of 2025, as well as deliver long-term value to our shareholders.”

The Board of Directors and management team extends its appreciation to Mr. Amezquita for his contributions to Herbalife.

About Herbalife Ltd.

Herbalife (NYSE: HLF) is a premier health and wellness company, community and platform that has been changing people’s lives with great nutrition products and a business opportunity for its independent distributors since 1980. The Company offers science-backed products to consumers in more than 90 markets through entrepreneurial distributors who provide one-on-one coaching and a supportive community that inspires their customers to embrace a healthier, more active lifestyle to live their best life.

For more information, visit https://ir.herbalife.com.

 

 

1 

Non-GAAP measure – refer to Schedule A – “Reconciliation of Non-GAAP Financial Measure” for a detailed reconciliation of this measure to the most directly comparable U.S. GAAP measure, as applicable, and a discussion of why the Company believes this non-GAAP measure is useful.

Forward-Looking Statements

This release contains “forward-looking statements” within the meaning of Section 27A of the Securities Act of 1933, as amended, and Section 21E of the Securities Exchange Act of 1934, as amended. All statements other than statements of historical fact are “forward-looking statements” for purposes of federal and state securities laws, including any projections of earnings, revenue or other financial items; any statements of the plans, strategies and objectives of management, including for future operations, capital expenditures, or share repurchases; any statements concerning proposed new products, services, or developments; any statements regarding future economic conditions or performance; any statements of belief or expectation; and any statements of assumptions underlying any of the foregoing or other future events. Forward-looking statements may include, among others, the words “may,” “will,” “estimate,” “intend,” “continue,” “believe,” “expect,” “anticipate” or any other similar words.

Although we believe that the expectations reflected in any of our forward-looking statements are reasonable, actual results or outcomes could differ materially from those projected or assumed in any of our forward-looking statements. Our future financial condition and results of operations, as well as any forward-looking statements, are subject to change and to inherent risks and uncertainties, many of which are beyond our control. Important factors that could cause our actual results, performance and achievements, or industry results to differ materially from estimates or projections contained in or implied by our forward-looking statements include the following:

 

  ●  

the potential impacts of current global economic conditions, including inflation, on us; our Members, customers, and supply chain; and the world economy;

  ●  

our ability to attract and retain Members;

  ●  

our relationship with, and our ability to influence the actions of, our Members;

  ●  

our noncompliance with, or improper action by our employees or Members in violation of, applicable U.S. and foreign laws, rules, and regulations;

  ●  

adverse publicity associated with our Company or the direct-selling industry, including our ability to comfort the marketplace and regulators regarding our compliance with applicable laws;

  ●  

changing consumer preferences and demands and evolving industry standards, including with respect to climate change, sustainability, and other environmental, social, and governance, or ESG, matters;

  ●  

the competitive nature of our business and industry;

  ●  

legal and regulatory matters, including regulatory actions concerning, or legal challenges to, our products or network marketing program and product liability claims;

  ●  

the Consent Order entered into with the FTC, the effects thereof and any failure to comply therewith;

  ●  

risks associated with operating internationally and in China;

  ●  

our ability to execute our growth and other strategic initiatives, including implementation of our Transformation Program and increased penetration of our existing markets;

  ●  

any material disruption to our business caused by natural disasters, other catastrophic events, acts of war or terrorism, including the war in Ukraine, cybersecurity incidents, pandemics, and/or other acts by third parties;

  ●  

our ability to adequately source ingredients, packaging materials, and other raw materials and manufacture and distribute our products;

  ●  

our reliance on our information technology infrastructure;

  ●  

noncompliance by us or our Members with any privacy laws, rules, or regulations or any security breach involving the misappropriation, loss, or other unauthorized use or disclosure of confidential information;

  ●  

contractual limitations on our ability to expand or change our direct-selling business model;

  ●  

the sufficiency of our trademarks and other intellectual property;

  ●  

product concentration;

  ●  

our reliance upon, or the loss or departure of any member of, our senior management team;

  ●  

restrictions imposed by covenants in the agreements governing our indebtedness;

  ●  

risks related to our convertible notes;

  ●  

changes in, and uncertainties relating to, the application of transfer pricing, income tax, customs duties, value added taxes, and other tax laws, treaties, and regulations, or their interpretation;

  ●  

our incorporation under the laws of the Cayman Islands; and

  ●  

share price volatility related to, among other things, speculative trading and certain traders shorting our common shares.

Additional factors and uncertainties that could cause actual results or outcomes to differ materially from our forward-looking statements are set forth in the Company’s Annual Report on Form 10-K for the fiscal year ended December 31, 2023, filed with the Securities and Exchange Commission on February 14, 2024, including under the headings “Risk Factors” and “Management’s Discussion and Analysis of Financial Condition and Results of Operations” and in our Consolidated Financial Statements and the related Notes included therein. In addition, historical, current, and forward-looking sustainability-related statements may be based on standards for measuring progress that are still developing, internal controls and processes that continue to evolve, and assumptions that are subject to change in the future.

Forward-looking statements made in this release speak only as of the date hereof. We do not undertake any obligation to update or release any revisions to any forward-looking statement or to report any events or circumstances after the date hereof or to reflect the occurrence of unanticipated events, except as required by law.

Supplemental Information

SCHEDULE A: RECONCILIATION OF NON-GAAP FINANCIAL MEASURE (unaudited)

Adjusted EBITDA

In addition to its reported results calculated in accordance with U.S. GAAP, the Company has included in this release adjusted EBITDA, a performance measure that the Securities and Exchange Commission defines as a “non-GAAP financial measure.” Adjusted EBITDA excludes the impact of certain unusual or non-recurring items such as expenses related to the Transformation Program, expenses related to the digital technology program, gain from extinguishment of debt and Korea tax settlement, as further detailed in the reconciliation below. Adjusted EBITDA margin represents adjusted EBITDA divided by net sales.

Management believes that such non-GAAP performance measure, when read in conjunction with the Company’s reported results, calculated in accordance with U.S. GAAP, can provide useful supplemental information for investors because it facilitates a period to period comparative assessment of the Company’s operating performance relative to its performance based on reported results under U.S. GAAP, while isolating the effects of some items that vary from period to period without any correlation to core operating performance and eliminate certain charges that management believes do not reflect the Company’s operations and underlying operational performance.

The Company’s definition and calculation as set forth in the table below of adjusted EBITDA may not be comparable to similarly titled measures used by other companies because other companies may not calculate it in the same manner as the Company does and should not be viewed in isolation from, nor as alternatives to, net income calculated in accordance with U.S. GAAP.

The Company does not provide a reconciliation of forward-looking adjusted EBITDA guidance to net income, the comparable U.S. GAAP measure, because, due to the unpredictable or unknown nature of certain significant items, such as income tax expenses or benefits, loss contingencies, and any gains or losses in connection with the potential refinancing transaction, we cannot reconcile this non-GAAP projection without unreasonable efforts. We expect the variability of these items, which are necessary for a presentation of the reconciliation, could have a significant impact on our reported U.S. GAAP financial results.

The following is a reconciliation of net income to EBITDA and adjusted EBITDA:

 

                 
   
(in millions)   

Three

Months

Ended

March 31,

2023

    

Year Ended
December

31, 2023

  
    

 

 

  
   

Net income

      $ 29.3     $ 142.2    

Interest expense, net

      39.4       154.4    

Income taxes

      1.8       60.8    

Depreciation and amortization

      27.6       113.3    
    

 

 

  

EBITDA

      98.1           470.7    

Amortization of SaaS implementation costs

      -       6.0    

Expenses related to Transformation Program1, 2

           27.3       54.2    

Digital technology program costs1, 2

      3.5       32.1    

Gain on extinguishment of debt1, 2

      -       (1.0)   

Korea tax settlement1, 2

      -       8.6    
    

 

 

  

Adjusted EBITDA

      $ 128.9     $ 570.6    
    

 

 

  
          

 

(1) 

Based on interim income tax reporting rules, these expenses are not considered discrete items. The tax effect of the adjustments between our U.S. GAAP and non-GAAP results takes into account the tax treatment and related tax rate(s) that apply to each adjustment in the applicable tax jurisdiction(s).

(2) 

Excludes tax (benefit)/expense as follows:

 

(in millions)   

Three

Months

Ended

March 31,

2023

    

Year Ended
December 31,

2023  

  
  

 

 

  

Expenses related to Transformation Program

      $ (6.0)     $ (10.6)   

Digital technology program costs

      (0.2)       (2.6)   

Gain on extinguishment of debt

           -               -      

Korea tax settlement

      -        (1.1)   
  

 

 

  

Total income tax adjustments

      $ (6.2)     $ (14.3)   
  

 

 

  

 

 
Contacts   
 

Media Contact:

Thien Ho

Vice President, Global Corporate Communications

thienh@herbalife.com

 

Investor Contact:

Erin Banyas

Vice President, Head of Investor Relations

erinba@herbalife.com

 

   

Source: Herbalife Ltd.

EX-101.SCH 3 hlf-20240317.xsd XBRL TAXONOMY EXTENSION SCHEMA 100000 - Document - Document and Entity Information link:calculationLink link:presentationLink link:definitionLink EX-101.LAB 4 hlf-20240317_lab.xml XBRL TAXONOMY EXTENSION LABEL LINKBASE Cover [Abstract] Cover [Abstract] Amendment Flag Amendment Flag Entity Central Index Key Entity Central Index Key Document Type Document Type Document Period End Date Document Period End Date Entity Registrant Name Entity Registrant Name Entity Incorporation State Country Code Entity Incorporation State Country Code Entity File Number Entity File Number Entity Tax Identification Number Entity Tax Identification Number Entity Address, Address Line One Entity Address, Address Line One Entity Address, City or Town Entity Address, City or Town Entity Address, Region Entity Address, Region Entity Address, Country Entity Address, Country Entity Address, Postal Zip Code Entity Address, Postal Zip Code Entity Information, Former Legal or Registered Name Entity Information, Former Legal or Registered Name City Area Code City Area Code Local Phone Number Local Phone Number Written Communications Written Communications Soliciting Material Soliciting Material Pre Commencement Tender Offer Pre Commencement Tender Offer Pre Commencement Issuer Tender Offer Pre Commencement Issuer Tender Offer Security 12b Title Security 12b Title Trading Symbol Trading Symbol Security Exchange Name Security Exchange Name Entity Emerging Growth Company Entity Emerging Growth Company EX-101.PRE 5 hlf-20240317_pre.xml XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE XML 7 R1.htm IDEA: XBRL DOCUMENT v3.24.1
Document and Entity Information
Mar. 17, 2024
Cover [Abstract]  
Amendment Flag false
Entity Central Index Key 0001180262
Document Type 8-K
Document Period End Date Mar. 17, 2024
Entity Registrant Name Herbalife Ltd.
Entity Incorporation State Country Code E9
Entity File Number 1-32381
Entity Tax Identification Number 98-0377871
Entity Address, Address Line One P.O. Box 309
Entity Address, City or Town Ugland House
Entity Address, Region Grand Cayman
Entity Address, Country KY
Entity Address, Postal Zip Code KY1-1104
Entity Information, Former Legal or Registered Name c/o (213) 745-0500
City Area Code c/o (213)
Local Phone Number 745-0500
Written Communications false
Soliciting Material false
Pre Commencement Tender Offer false
Pre Commencement Issuer Tender Offer false
Security 12b Title Common Shares, par value $0.0005 per share
Trading Symbol HLF
Security Exchange Name NYSE
Entity Emerging Growth Company false
EXCEL 8 Financial_Report.xlsx IDEA: XBRL DOCUMENT begin 644 Financial_Report.xlsx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end XML 9 Show.js IDEA: XBRL DOCUMENT // Edgar(tm) Renderer was created by staff of the U.S. Securities and Exchange Commission. Data and content created by government employees within the scope of their employment are not subject to domestic copyright protection. 17 U.S.C. 105. var Show={};Show.LastAR=null,Show.showAR=function(a,r,w){if(Show.LastAR)Show.hideAR();var e=a;while(e&&e.nodeName!='TABLE')e=e.nextSibling;if(!e||e.nodeName!='TABLE'){var ref=((window)?w.document:document).getElementById(r);if(ref){e=ref.cloneNode(!0); e.removeAttribute('id');a.parentNode.appendChild(e)}} if(e)e.style.display='block';Show.LastAR=e};Show.hideAR=function(){Show.LastAR.style.display='none'};Show.toggleNext=function(a){var e=a;while(e.nodeName!='DIV')e=e.nextSibling;if(!e.style){}else if(!e.style.display){}else{var d,p_;if(e.style.display=='none'){d='block';p='-'}else{d='none';p='+'} e.style.display=d;if(a.textContent){a.textContent=p+a.textContent.substring(1)}else{a.innerText=p+a.innerText.substring(1)}}} XML 10 report.css IDEA: XBRL DOCUMENT /* Updated 2009-11-04 */ /* v2.2.0.24 */ /* DefRef Styles */ ..report table.authRefData{ background-color: #def; border: 2px solid #2F4497; font-size: 1em; position: absolute; } ..report table.authRefData a { display: block; font-weight: bold; } ..report table.authRefData p { margin-top: 0px; } ..report table.authRefData .hide { background-color: #2F4497; padding: 1px 3px 0px 0px; text-align: right; } ..report table.authRefData .hide a:hover { background-color: #2F4497; } ..report table.authRefData .body { height: 150px; overflow: auto; width: 400px; } ..report table.authRefData table{ font-size: 1em; } /* Report Styles */ ..pl a, .pl a:visited { color: black; text-decoration: none; } /* table */ ..report { background-color: white; border: 2px solid #acf; clear: both; color: black; font: normal 8pt Helvetica, Arial, san-serif; margin-bottom: 2em; } ..report hr { border: 1px solid #acf; } /* Top labels */ ..report th { background-color: #acf; color: black; font-weight: bold; text-align: center; } ..report th.void { background-color: transparent; color: #000000; font: bold 10pt Helvetica, Arial, san-serif; text-align: left; } ..report .pl { text-align: left; vertical-align: top; white-space: normal; width: 200px; white-space: normal; /* word-wrap: break-word; */ } ..report td.pl a.a { cursor: pointer; display: block; width: 200px; overflow: hidden; } ..report td.pl div.a { width: 200px; } ..report td.pl a:hover { background-color: #ffc; } /* Header rows... */ ..report tr.rh { background-color: #acf; color: black; font-weight: bold; } /* Calendars... */ ..report .rc { background-color: #f0f0f0; } /* Even rows... */ ..report .re, .report .reu { background-color: #def; } ..report .reu td { border-bottom: 1px solid black; } /* Odd rows... */ ..report .ro, .report .rou { background-color: white; } ..report .rou td { border-bottom: 1px solid black; } ..report .rou table td, .report .reu table td { border-bottom: 0px solid black; } /* styles for footnote marker */ ..report .fn { white-space: nowrap; } /* styles for numeric types */ ..report .num, .report .nump { text-align: right; white-space: nowrap; } ..report .nump { padding-left: 2em; } ..report .nump { padding: 0px 0.4em 0px 2em; } /* styles for text types */ ..report .text { text-align: left; white-space: normal; } ..report .text .big { margin-bottom: 1em; width: 17em; } ..report .text .more { display: none; } ..report .text .note { font-style: italic; font-weight: bold; } ..report .text .small { width: 10em; } ..report sup { font-style: italic; } ..report .outerFootnotes { font-size: 1em; } XML 12 FilingSummary.xml IDEA: XBRL DOCUMENT 3.24.1 html 1 24 1 false 0 0 false 0 false false R1.htm 100000 - Document - Document and Entity Information Sheet http://www.herbalife.com//20240317/taxonomy/role/DocumentDocumentAndEntityInformation Document and Entity Information Cover 1 false false All Reports Book All Reports d809540d8k.htm hlf-20240317.xsd hlf-20240317_lab.xml hlf-20240317_pre.xml http://xbrl.sec.gov/dei/2023 true false JSON 14 MetaLinks.json IDEA: XBRL DOCUMENT { "version": "2.2", "instance": { "d809540d8k.htm": { "nsprefix": "hlf", "nsuri": "http://www.herbalife.com/20240317", "dts": { "inline": { "local": [ "d809540d8k.htm" ] }, "schema": { "local": [ "hlf-20240317.xsd" ], "remote": [ "http://www.xbrl.org/2003/xbrl-instance-2003-12-31.xsd", "http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd", "http://www.xbrl.org/2003/xl-2003-12-31.xsd", "http://www.xbrl.org/2003/xlink-2003-12-31.xsd", "http://www.xbrl.org/2005/xbrldt-2005.xsd", "http://www.xbrl.org/dtr/type/nonNumeric-2009-12-16.xsd", "http://www.xbrl.org/dtr/type/numeric-2009-12-16.xsd", "https://www.xbrl.org/dtr/type/2022-03-31/types.xsd", "https://xbrl.sec.gov/dei/2023/dei-2023.xsd", "https://xbrl.sec.gov/naics/2023/naics-2023.xsd" ] }, "labelLink": { "local": [ "hlf-20240317_lab.xml" ] }, "presentationLink": { "local": [ "hlf-20240317_pre.xml" ] } }, "keyStandard": 24, "keyCustom": 0, "axisStandard": 0, "axisCustom": 0, "memberStandard": 0, "memberCustom": 0, "hidden": { "total": 2, "http://xbrl.sec.gov/dei/2023": 2 }, "contextCount": 1, "entityCount": 1, "segmentCount": 0, "elementCount": 25, "unitCount": 0, "baseTaxonomies": { "http://xbrl.sec.gov/dei/2023": 24 }, "report": { "R1": { "role": "http://www.herbalife.com//20240317/taxonomy/role/DocumentDocumentAndEntityInformation", "longName": "100000 - Document - Document and Entity Information", "shortName": "Document and Entity Information", "isDefault": "true", "groupType": "document", "subGroupType": "", "menuCat": "Cover", "order": "1", "firstAnchor": { "contextRef": "duration_2024-03-17_to_2024-03-17", "name": "dei:DocumentType", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "span", "p", "div", "div", "body", "html" ], "reportCount": 1, "baseRef": "d809540d8k.htm", "first": true, "unique": true }, "uniqueAnchor": { "contextRef": "duration_2024-03-17_to_2024-03-17", "name": "dei:DocumentType", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "span", "p", "div", "div", "body", "html" ], "reportCount": 1, "baseRef": "d809540d8k.htm", "first": true, "unique": true } } }, "tag": { "dei_AmendmentFlag": { "xbrltype": "booleanItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "AmendmentFlag", "presentation": [ "http://www.herbalife.com//20240317/taxonomy/role/DocumentDocumentAndEntityInformation" ], "lang": { "en-us": { "role": { "label": "Amendment Flag", "terseLabel": "Amendment Flag", "documentation": "Boolean flag that is true when the XBRL content amends previously-filed or accepted submission." } } }, "auth_ref": [] }, "dei_CityAreaCode": { "xbrltype": "normalizedStringItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "CityAreaCode", "presentation": [ "http://www.herbalife.com//20240317/taxonomy/role/DocumentDocumentAndEntityInformation" ], "lang": { "en-us": { "role": { "label": "City Area Code", "terseLabel": "City Area Code", "documentation": "Area code of city" } } }, "auth_ref": [] }, "dei_CoverAbstract": { "xbrltype": "stringItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "CoverAbstract", "lang": { "en-us": { "role": { "label": "Cover [Abstract]", "terseLabel": "Cover [Abstract]", "documentation": "Cover page." } } }, "auth_ref": [] }, "dei_DocumentPeriodEndDate": { "xbrltype": "dateItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "DocumentPeriodEndDate", "presentation": [ "http://www.herbalife.com//20240317/taxonomy/role/DocumentDocumentAndEntityInformation" ], "lang": { "en-us": { "role": { "label": "Document Period End Date", "terseLabel": "Document Period End Date", "documentation": "For the EDGAR submission types of Form 8-K: the date of the report, the date of the earliest event reported; for the EDGAR submission types of Form N-1A: the filing date; for all other submission types: the end of the reporting or transition period. The format of the date is YYYY-MM-DD." } } }, "auth_ref": [] }, "dei_DocumentType": { "xbrltype": "submissionTypeItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "DocumentType", "presentation": [ "http://www.herbalife.com//20240317/taxonomy/role/DocumentDocumentAndEntityInformation" ], "lang": { "en-us": { "role": { "label": "Document Type", "terseLabel": "Document Type", "documentation": "The type of document being provided (such as 10-K, 10-Q, 485BPOS, etc). The document type is limited to the same value as the supporting SEC submission type, or the word 'Other'." } } }, "auth_ref": [] }, "dei_EntityAddressAddressLine1": { "xbrltype": "normalizedStringItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "EntityAddressAddressLine1", "presentation": [ "http://www.herbalife.com//20240317/taxonomy/role/DocumentDocumentAndEntityInformation" ], "lang": { "en-us": { "role": { "label": "Entity Address, Address Line One", "terseLabel": "Entity Address, Address Line One", "documentation": "Address Line 1 such as Attn, Building Name, Street Name" } } }, "auth_ref": [] }, "dei_EntityAddressCityOrTown": { "xbrltype": "normalizedStringItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "EntityAddressCityOrTown", "presentation": [ "http://www.herbalife.com//20240317/taxonomy/role/DocumentDocumentAndEntityInformation" ], "lang": { "en-us": { "role": { "label": "Entity Address, City or Town", "terseLabel": "Entity Address, City or Town", "documentation": "Name of the City or Town" } } }, "auth_ref": [] }, "dei_EntityAddressCountry": { "xbrltype": "countryCodeItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "EntityAddressCountry", "presentation": [ "http://www.herbalife.com//20240317/taxonomy/role/DocumentDocumentAndEntityInformation" ], "lang": { "en-us": { "role": { "label": "Entity Address, Country", "terseLabel": "Entity Address, Country", "documentation": "ISO 3166-1 alpha-2 country code." } } }, "auth_ref": [] }, "dei_EntityAddressPostalZipCode": { "xbrltype": "normalizedStringItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "EntityAddressPostalZipCode", "presentation": [ "http://www.herbalife.com//20240317/taxonomy/role/DocumentDocumentAndEntityInformation" ], "lang": { "en-us": { "role": { "label": "Entity Address, Postal Zip Code", "terseLabel": "Entity Address, Postal Zip Code", "documentation": "Code for the postal or zip code" } } }, "auth_ref": [] }, "dei_EntityAddressRegion": { "xbrltype": "normalizedStringItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "EntityAddressRegion", "presentation": [ "http://www.herbalife.com//20240317/taxonomy/role/DocumentDocumentAndEntityInformation" ], "lang": { "en-us": { "role": { "label": "Entity Address, Region", "terseLabel": "Entity Address, Region", "documentation": "Name of the region." } } }, "auth_ref": [] }, "dei_EntityCentralIndexKey": { "xbrltype": "centralIndexKeyItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "EntityCentralIndexKey", "presentation": [ "http://www.herbalife.com//20240317/taxonomy/role/DocumentDocumentAndEntityInformation" ], "lang": { "en-us": { "role": { "label": "Entity Central Index Key", "terseLabel": "Entity Central Index Key", "documentation": "A unique 10-digit SEC-issued value to identify entities that have filed disclosures with the SEC. It is commonly abbreviated as CIK." } } }, "auth_ref": [ "r1" ] }, "dei_EntityEmergingGrowthCompany": { "xbrltype": "booleanItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "EntityEmergingGrowthCompany", "presentation": [ "http://www.herbalife.com//20240317/taxonomy/role/DocumentDocumentAndEntityInformation" ], "lang": { "en-us": { "role": { "label": "Entity Emerging Growth Company", "terseLabel": "Entity Emerging Growth Company", "documentation": "Indicate if registrant meets the emerging growth company criteria." } } }, "auth_ref": [ "r1" ] }, "dei_EntityFileNumber": { "xbrltype": "fileNumberItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "EntityFileNumber", "presentation": [ "http://www.herbalife.com//20240317/taxonomy/role/DocumentDocumentAndEntityInformation" ], "lang": { "en-us": { "role": { "label": "Entity File Number", "terseLabel": "Entity File Number", "documentation": "Commission file number. The field allows up to 17 characters. The prefix may contain 1-3 digits, the sequence number may contain 1-8 digits, the optional suffix may contain 1-4 characters, and the fields are separated with a hyphen." } } }, "auth_ref": [] }, "dei_EntityIncorporationStateCountryCode": { "xbrltype": "edgarStateCountryItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "EntityIncorporationStateCountryCode", "presentation": [ "http://www.herbalife.com//20240317/taxonomy/role/DocumentDocumentAndEntityInformation" ], "lang": { "en-us": { "role": { "label": "Entity Incorporation State Country Code", "terseLabel": "Entity Incorporation State Country Code", "documentation": "Two-character EDGAR code representing the state or country of incorporation." } } }, "auth_ref": [] }, "dei_EntityInformationFormerLegalOrRegisteredName": { "xbrltype": "normalizedStringItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "EntityInformationFormerLegalOrRegisteredName", "presentation": [ "http://www.herbalife.com//20240317/taxonomy/role/DocumentDocumentAndEntityInformation" ], "lang": { "en-us": { "role": { "label": "Entity Information, Former Legal or Registered Name", "terseLabel": "Entity Information, Former Legal or Registered Name", "documentation": "Former Legal or Registered Name of an entity" } } }, "auth_ref": [] }, "dei_EntityRegistrantName": { "xbrltype": "normalizedStringItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "EntityRegistrantName", "presentation": [ "http://www.herbalife.com//20240317/taxonomy/role/DocumentDocumentAndEntityInformation" ], "lang": { "en-us": { "role": { "label": "Entity Registrant Name", "terseLabel": "Entity Registrant Name", "documentation": "The exact name of the entity filing the report as specified in its charter, which is required by forms filed with the SEC." } } }, "auth_ref": [ "r1" ] }, "dei_EntityTaxIdentificationNumber": { "xbrltype": "employerIdItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "EntityTaxIdentificationNumber", "presentation": [ "http://www.herbalife.com//20240317/taxonomy/role/DocumentDocumentAndEntityInformation" ], "lang": { "en-us": { "role": { "label": "Entity Tax Identification Number", "terseLabel": "Entity Tax Identification Number", "documentation": "The Tax Identification Number (TIN), also known as an Employer Identification Number (EIN), is a unique 9-digit value assigned by the IRS." } } }, "auth_ref": [ "r1" ] }, "dei_LocalPhoneNumber": { "xbrltype": "normalizedStringItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "LocalPhoneNumber", "presentation": [ "http://www.herbalife.com//20240317/taxonomy/role/DocumentDocumentAndEntityInformation" ], "lang": { "en-us": { "role": { "label": "Local Phone Number", "terseLabel": "Local Phone Number", "documentation": "Local phone number for entity." } } }, "auth_ref": [] }, "dei_PreCommencementIssuerTenderOffer": { "xbrltype": "booleanItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "PreCommencementIssuerTenderOffer", "presentation": [ "http://www.herbalife.com//20240317/taxonomy/role/DocumentDocumentAndEntityInformation" ], "lang": { "en-us": { "role": { "label": "Pre Commencement Issuer Tender Offer", "terseLabel": "Pre Commencement Issuer Tender Offer", "documentation": "Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act." } } }, "auth_ref": [ "r3" ] }, "dei_PreCommencementTenderOffer": { "xbrltype": "booleanItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "PreCommencementTenderOffer", "presentation": [ "http://www.herbalife.com//20240317/taxonomy/role/DocumentDocumentAndEntityInformation" ], "lang": { "en-us": { "role": { "label": "Pre Commencement Tender Offer", "terseLabel": "Pre Commencement Tender Offer", "documentation": "Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act." } } }, "auth_ref": [ "r4" ] }, "dei_Security12bTitle": { "xbrltype": "securityTitleItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "Security12bTitle", "presentation": [ "http://www.herbalife.com//20240317/taxonomy/role/DocumentDocumentAndEntityInformation" ], "lang": { "en-us": { "role": { "label": "Security 12b Title", "terseLabel": "Security 12b Title", "documentation": "Title of a 12(b) registered security." } } }, "auth_ref": [ "r0" ] }, "dei_SecurityExchangeName": { "xbrltype": "edgarExchangeCodeItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "SecurityExchangeName", "presentation": [ "http://www.herbalife.com//20240317/taxonomy/role/DocumentDocumentAndEntityInformation" ], "lang": { "en-us": { "role": { "label": "Security Exchange Name", "terseLabel": "Security Exchange Name", "documentation": "Name of the Exchange on which a security is registered." } } }, "auth_ref": [ "r2" ] }, "dei_SolicitingMaterial": { "xbrltype": "booleanItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "SolicitingMaterial", "presentation": [ "http://www.herbalife.com//20240317/taxonomy/role/DocumentDocumentAndEntityInformation" ], "lang": { "en-us": { "role": { "label": "Soliciting Material", "terseLabel": "Soliciting Material", "documentation": "Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as soliciting material pursuant to Rule 14a-12 under the Exchange Act." } } }, "auth_ref": [ "r5" ] }, "dei_TradingSymbol": { "xbrltype": "tradingSymbolItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "TradingSymbol", "presentation": [ "http://www.herbalife.com//20240317/taxonomy/role/DocumentDocumentAndEntityInformation" ], "lang": { "en-us": { "role": { "label": "Trading Symbol", "terseLabel": "Trading Symbol", "documentation": "Trading symbol of an instrument as listed on an exchange." } } }, "auth_ref": [] }, "dei_WrittenCommunications": { "xbrltype": "booleanItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "WrittenCommunications", "presentation": [ "http://www.herbalife.com//20240317/taxonomy/role/DocumentDocumentAndEntityInformation" ], "lang": { "en-us": { "role": { "label": "Written Communications", "terseLabel": "Written Communications", "documentation": "Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as written communications pursuant to Rule 425 under the Securities Act." } } }, "auth_ref": [ "r6" ] } } } }, "std_ref": { "r0": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Exchange Act", "Number": "240", "Section": "12", "Subsection": "b" }, "r1": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Exchange Act", "Number": "240", "Section": "12", "Subsection": "b-2" }, "r2": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Exchange Act", "Number": "240", "Section": "12", "Subsection": "d1-1" }, "r3": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Exchange Act", "Number": "240", "Section": "13e", "Subsection": "4c" }, "r4": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Exchange Act", "Number": "240", "Section": "14d", "Subsection": "2b" }, "r5": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Exchange Act", "Section": "14a", "Number": "240", "Subsection": "12" }, "r6": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Securities Act", "Number": "230", "Section": "425" } } } ZIP 15 0001193125-24-072046-xbrl.zip IDEA: XBRL DOCUMENT begin 644 0001193125-24-072046-xbrl.zip M4$L#!!0 ( $XY=%@8N4,J>A( %!L . 9#@P.34T,&0X:RYH=&WM M76USXC@2_IY?H6)O=Y.J #:0!$B&*X8P,^QFDE3(W.[>ERUA"]".L;R2G,#] M^NN6;;!Y"22!9.8N4[4S@/72:O7+TZVV]NR?XY%'[IA47/CO?K8+UL^$^8YP MN3]X]W.SV^IT?OYG8^]LJ*$9-/55W67\76ZH=5 O%L<]Z144$!\62 M52KGXH:ARNM)P-2T=9^J7D'(03%YDFGN"]\/1]/&]_?W!3,\=G"U+&*/(C3* M0RLFN9/T&WO<_YKI=E\VG>Q:K58T3Y.F"RVG$Y0LJUS$QSVJ6-)\Z/4SK8=, M]JC'^ZS@B!'27K'*]LF4#L6740$CV\7?/U]TG2$;T3SWE::^,YTCU'(E1;4B M/$T:KP*,3E'V6:Y S M/JYC:R;CS]QUF1]]AB:7D> 3GXZP+^/UYHCY+ORG/WAT$%,PUC<,Y-8-I>'N MGRBG>:NX^R['QW?YTM%QKM&GGF)GQ!-?QM*7"18DGQB+PICY29/J72D0$%8/T:[$J&,OAJUJ3;LSLU?0K=_&'/F>2& ZRI4K=ZOR:W9_Y MSDCUTO$#V$#A3K^"/DM]3C5KS&A+>LZ>S6AU5[1-GDRGG:+4L!48A"PN@/1A:_**_X?5 M[>KT>Y^.N#>IW_(14^22W9,;,:+^J7EV']'=$YY[NF1[OEQV;MOGI'O;O&UW M5Y-CO1 YW7;KRTWGMM/NDN;E.6G_WOK4O/S8)JVKSY\[W6[GZO)9-):V0>-O MS>ZGSN7'VZO+0W)>:!5(R3JJU.;HFIMTG61F!6*=1BV5S.,G26;!@F99X3R- MM+1D_[BX^@VU=+:8Q$@LV[!H.UY JCY?C%8> K[R4- M0* . 8_8J!2UCV?%9&NQIOX[$1\MJ+P8))NVI>WY*9] M?75S^_H&Z#J4*J2^)EJ0+G-0 (E=)D(2^VC?/7A] D6?Z"%#VD+)-8?^[;$S MI/Z D::C"3RV:^7*:CI?;&<1!B$YD@5":K*??&<48!!3FK [:!D_9NY!?768 MD1B):X.EVA'$>K2UB (^M!BZ[L( (^@^=.ED A0Q/VU-JKG&9X#&0V*?'!(< M8M&PO%F4[5N44F4;8PXS/,0)V&R,V?ES/> NF[R/9XJ7JHC/(\&BM63#P^+1TJ6$.A%S+ M MZ\>8=74KIK)N)?$?T"7-WVXVJ"Q7?L3X/_W@CDG-'>K%7(T6.M\H[EW:K'=" MXD+K]#!GQ9A$F3P-Z(#E>Y+1KYC$!%=H[$]7@W]JB=#7=$@V;\W0G$S"TZ ;:0CO*H[ZJ50%J[FXC!5-;GF^^$KT^./2+&?^ > M@V<],$E/]@4G=JYAY\NER;K_70[>TG$G3K@YAF7/9F>3D^K) M)AS=@56H;LI)48CKM2WL"=H"TFDO?^WV]&YZ9+V*/#$A,E7WY"L7267HC#; M%V/TX"^$DM\K,C51SALTW2$TC92QQN"Y;$)/1@H]7\E;<^\^@I9)K?!D@OB:? M1+AXV'WX^NF"S9B!603Q'$8975?D@]Q@/;LX"R.R7"6 M;%QVO#XN>P4?G8RWXZ@B9O*U4)IZ_^;!D^+@&2]/9^/P%% MQHZOV8']F(68^;N6W'=X0#W2'C,GU/R.D:L^ NF#K[EV'0?=I[@UA\L;,\2 MZ//(9[(:(G0D&$8!-!?M:Y MGHX_+5'[ !^8O& #ZEW):$(FF?NL!':U]H *HK]K J7/5+IJKN$4!=DOV>6# MQ>SXDPW$A0 AND8&/SO3 $PXJ1SEK2/+6FD6-O5.+R9RET*39A!XH$N@ ,^! M#=L)F2+QC$\9)(F_QM8'A+^/IPO^@+FD"XK R 55FMR8@[^W\X;=',ZODS- M%D/F?#5GR30(I @DQUQ1#W!RCWGB'G<-'^)FKE=54WQAU(7TN8=VCBLP>IKY M+NRZ%D3Q4>AIZC- OMZ$*-!0U9^8&>(.H@?\BL+<^(Q;SDZK0AA'$NI/DF=] MB#3%/?;#K#;'[(FJKY2EXZ?&P5N-C:V[0GA]2CLE0;)2AG>JJG3JYU4*J>+!G8-#IE/ M$I'LUI)GV^"Y\LE<(^8-,"/-'!*DBD5N0A"72NDH%M6Y&@TLS=BW3TCKPPTI ME:T"-'Q,(N=-?M?+;Q=LL0/<]@>?P9"!-?-V)[SV]R2\,\; T!%G%B5WK86W M*S1OEQ(C/Q/R3/51(N)K1RM5K$(TXD&J2.]-&[:F#=>2H27'0GU37HF.6$+ M]P2PO+%6E+XGK5@KHL#!O)-B82+ZZWS !IKDYDO[O8/MZE(TYILVO80V=90* MF7P1G2J_Z=1&.E5F^V'J*E *2<)GTRW(E+E"/MM-$") $2 M+'=U//3M'PR^E:QM.9>\0?YBQ1*7J,>KGHG?XNNP426Y,R2.1Y5ZF7.0I[+P MM?DE*:KG64\6&]W)")KMJQ>J[G@!CNTBH9F42QL!8[$#>?5:$.$3T$6@:.8+ MLB[IFZL]6!.P1]YM8I=Z1J6?GL6O5G(-Q&? H>Z02J8.24 EN:->R,@_+! [ MZX@$^"8Q/GTTD-K-N=?1B(*_CNPA\&>E-B&-R\C#B5U!U9FHV MYQ+A7!% K@"><=(!&4AQKX>(GP-,CE-%7-;G?O1*1Y22!-%??&=L]JI8F>SC M5I^<1GG)I#7, \P)\(T0/-+9$(67>OEIBFBS%]6FLV\&R1>X2;>/IE#C?$R%Y=*5T6'2>Z#059YGTZ#K+1$%\B4[:NBKDWN4=C@GH3O M^$*&Z%@S/MS[GB/E!&S498D&+9IZ4"6/664!KLOE+" MP8->-]*0]IAK5(]SK@*A0"M D/F=,=>%!UY?/-Z&N;CRB7G+-M:K^%7;0Z-8 M[P6H(VK9.9>@?4*:(J;LZY9D'UOB&DO6:6Q6S3?[]" ZT[Z#98)%PG-HZ''OPS&4*=C$ZH^Z9GSUS!8L:\@!B2Z'0!0M#4VH*4^6#UHMI M],>F-]@3,%H2#1Q,[881(R<%>BA%.!B*4!M. MF&-S#?(^0ITD'*9B45TZYEZC=;#L\&P< +?,\, V,?!A*PC5N":ER3^.K8C7 ML!]>?,Z^UNT&DN4U'2=.%V?P%$&Z7S(@5=WK21'!:M4(.<, @?DZYSL2=("6$MAT5'1G%2GI.W% M]P.DFYYB88Z ;38["T\6^^%F 0\I-)^0II3H0+"U6M;\U;2PZ;$Q:8[8?_X. MN:: ]*E*-DW>,42:RW2B->2L3SY,G6R\#-(#F;X'J3.HA_L0EJ5',J@AENS8 ML\8#/[3\[8"65>O_10Q]$(,C/-LM503XDUZ[@&:V:N$HLF,7*"XUD+9)=6DKW6P+9$?CI/8F5- M;?Q#3/Q,<6%V-29D1ED!B3:[9#0LQ'21\# CLLB!339Q497-_+]0/V:N;4UI MB$A:QNN_A(E)=<83DDMPT%B^"=VL$W,A ?,YR*79WRE/#J%+])(@2U%S#<[; M-_6TP*HF./>)XI$K1E4%!SP2*:\$V(8GIGK%)-'0+"+\)SH*3A$4:D44#Y;OE5;MEYP!HPC;S$^?4\AV@$\:B9W.)Y]X1CO0U ZK,YNNB/N MF]C'D&CX^UY.,/AH"<]C$%[L@["0K_"7CVR*'W[QN;DX54\.'C0Q.W>=)P7+ MQJLE0B]:P8=S9!V")P-07LB!P6:D$>14SO"L%H00_P?*U6L,F028:HU,=44/*:+4HD_ Z3]A"(Q3,)2;1 -][C$W MC@7,QD$X#S: J<@ I,/YZH:)*K.E=!1E']*11[IQ$GX<(F(4F+^[YR!L*NS] M!9,FULCCM,>]:"HS.2!T%6-)7/VRA67V,+UY&%((D^F(ZVA7UA_&^;Z5"\DV MSRQE/M=QB*MNNYY\V/HKT'M[4;&#^<4*M,RQ/BP7=Y>+AX+K2TM !-_B,/J58=52T]B:(DNA+9K5JUHXKE MLG&M9A>&>F2JDP AW,0((08.8,'FTDYB'G"@^-%5Y[ IGBRP)'D#!1X45SZ9 MO?%7>K&7S#?<*_,NYP_?F) &RZN-;]I@O+FMUWUGO=OY>-F\_7+3 M[CX%QIH!N8\Q(%:%/LYAI2\+C5#^WR&7LV3>1K!RR>&7&P*(S44$A;F_D]ZRWG_.%?O M:SS=YAYS54'?IL,L[WVT)2)>TVTO7]\C:TC675%RM'BSYE-]*TKT"N=J'F6] MZP;-*J_EA%=?NY#%QEELLJUW^S=[=3]+R?M)?4?3/^M2&U.;M^;,^I&.H*B* MY%/[\N8/TBJ0WYJ7'U^X,._EE'2K8QHIPI*O^HX$!,R(+R=F4\#QOFW(1AMB MBC%WMB/M?UT?DH_,!SSO$;Q!1S$O.N^89OD!,DFFJ9PL0^WS VWP $0 &0X,#DU-#!D97@Y M.3$N:'1M[5WI4R,YLO_N"/\/"F9ZHSO"&!LPS37$,V :=FGH!7KF]?LF5\FV MAG*51U5E\/SU+S,EU>$;FG/LWHT!RF4=J9\R4WEI__3FZ_G!_FFC?GQ0+.S? MG-V<-PX:_[NZLU.N[J_I/^'YFGF![1]>'O]@AU^.+L\OKWY;^>/T[*:QPJYO M?IPW?EOQI"]6.T*V.]'N1:"ZW%LY8,4"?/](^)%0!_O'9[_;E^^D&W5VM\LU MZ:\P[LFV#PV(5K1"W7RSKW6Y:DM_-0IZNY5>M,?,W\T@BH*N?M0*_&@UE'^+ MW6KZ=XMWI3?8K5^=U<]76/W\[,O%;RL*A[9RL']XT+COR*:,&,Z3[:\='NRO M?<.)CNNWNCV[X_7I'3LT?^KY5*@F3+)^*",9^.S, MAY\\@@^^Q-+E\ HTK=B)5&'$_AMS!6TQ[KOL)/:\U1^"JUE3F(-T\\]@O;*^ MF70X?JET:X]:*^SA_/*:U2^^-,X;UR7JZ2M73N=??C/L[:U72HQ&\*]?JK7* M'DOH62R<1VZ9?;SX<=W89:?G)Y]*C+.>$ET)Y.H([D4=HMJ=\#Q?A"%S@FZ/ M^X,2_M*-@>@#^KSG\0CHW2VQ*' Y/M/KY+*H(QCO]0+I1UV@!PM:[-]!QV?' MXEIV Q\^A+7L2-&"M?)AW23WV&6K)1VA2BR,'4<(5_IM5O?$/:MWQ=]_Q3+B M[*X3L#OI>0S&RJ4/O\-(L:\C/< R^ZK*>O9)3QWHJBF$#Z,K%L2]<.)(]F$ M44H0 @TVT^. F^IG-@"DA"4F?<>+:1S=0 EX@_ML6W]($P PME30!2I7*Y;* M\/LV$6%%!'Q:B14LNF">XB^N-JXJK)+N E5 P M<=\32@I\A18X72=LA&M\A&$K]EBDN'.+! B46\*^M_=8R*7+ODJGPP5,'8<2 M!GX)X,8E<%J?&M'8:R1H,-@K,SW^/P1 QI.B;T9P'8D>+OX7Q:._)?=E?E5= M)?N(DIDK"]1=1=YO5[6M@CNSUXADK<")0VP)>%L0*]IN4N\@6#J@"[ZI%P;@ MJ80; XU[47:%:*>S: M%J-8^?A;9F1=?B^[L.@L[,#7.H$'B\;ZW(L%;! &^-!;T$?NBN][ 4P 6&"W M;!;D>9!V!BOINC3X4K$ 4^-M0922N-^A01\)"5,)FK0G]!X.(]Z4'C(P&#L. MNXD$!S25V2$/@0H!/D;HPDQ@:C!532)H(%+"=T/;GEO* !.^(+4LPD[;66&$ MG;1((/V5$4@M%$C(((A%Z]TX2:K^G(B8)@Q)/"2B_FVWJ"R4 W[(OZM7?Q)?C/E7YP-69MD5*)JOH+2M]6:\5\GYTVSKZ< MW@"! ,JTTE^.TJ\$U@V;N\'X",F = M!Q-H?7'YQU7]6]J#BVJ"W0D;O8CMH2S;RV_PXCT+ P^VQB\M^I?R\]'M6,MMQV5K$UL; MPWJ?DB.!,)Z$I$V-I(P\9WD)SL;J%>81VAAVJ^5*173W0)^[CV"LJ.[NKMJ' MB(A=PU$@1,W@*7:2X;]S;:C-9$/-5-!GOE#]D&Q).(7![.!,MK=A M'@Y6@]4!S;BV9U3\Y,?3,)!'3+M:6J^MEZO)L-XO[2OC:%][R[2OE2I;Z^7- M+.T?HHBY&_B_,;Q[K'Y4FZU"/=\KXQ4Q,X&%97MU]\\XC(1;+#0.SVZ.Z_O7 MW\<*EEX=W%Z!]7]-?C"P>ORS&JU9FU.U8U* N77XV?K MV^6=5^=FMQ&?>&U=95!YRQ'LRXAYKW/>$[\HH5J^M M16TDT-]\ \C?J)0W7IT=5-=3)OFY]OI$J6[4RI41=H#^23+)/8LY%GTEPK5V MU;R!,S6)HFFUUU/!O>SR2'@#]BN B$A@K"3H*PHYVM-#[?7@S!=W+%!M[LN_ M.=I[.3J 7!&"H$2?PI_"B;#/8L&X@=#^RWUXIR_%'1ID84S_YG[,U<"86V_0 MQ&N^B@X(Z71P9*'H<07#TATGYET\?V_MA=KS2'9T\CY^4T%;\6Y)NZ2:"GO2 M/HVP(WO,\8)0)#X7H.JMB,(2"R-@7EWT M#S[+RT?\-QA"=H%#! -W8BV9?1 M ,><^+G(1>)$(31>++C"DWTT[4;8>QBQ7[='*:IBH >VF2-ME"%#QF@.Y (R MU?)=:?<$ M#K=8 /X7*2!+C 2WBZ>7 'U'!H9F?C ZHX-!0V0W>5[/UYG&2I=U C]0PUZ5 M[H"IP!/&>9AS6.7CARA$/.2\1\;KA.^W51"&:;?X=H!M;I0K]ZPY M(/(+;*E%>"KAO-'KA#\M:M%;M(K>(N-20H=-K(J%C+,I?%Y'$H+\,."*QGDL M ==1H$+C^DJ\2A%L6J!J1"X@&6DNANY5VK@PZL3SG+JKT?V#.\R!3I5LQO@J M[9UD!9[3\5-O!G'6R4U._^>+1D@[R@06:"?PE-""8F%&; %ZW:/4B>]TN-_6 MF QZ7L*9$4NA]M6V@;U&S(^!XK0TAHF&QGEL_7T [UZ@(MTA+A2N*6IIJ&61 M4U>&>M$0#/ =P'QU9[N29XI!JR7P8X>VVFJ3.[?"3;N$I8:U#^,NO@0,+0TC MV*F@SY)$ CQ00=SNP%8!T0"T\@6P-MB$N1&@DQQW*FB\LWGJS!> QZP&/OQ? MY&TE,%SN=)"^UM5.5$+O9[H\M"*@?/=@K^#HA53, 1X;T#314=UM*HZ*A;Z,I21 MT<2RM)O#PVAM'95*K;:-!Y?O!YTHZH6[:VM2E3O)3@?Z[:]]3XQ24WM9.<#Y MFX69Y)#=?J!#-LMEL@%HV^7*K):0X,U 2^V3S(F[PK]V]-A:NOH11WG!'X* M9V[&-SSL0Q[V,6=]RO8$J0'W&YMTADS.A_;+'U;R1T7SNPZ^>YPM9U3;SS:: MZ^[!A\^9\-]CPW.8Q2_6?;0!3T/#J#VK*-$2VNXUTX'U *@;MU^ MI-64*U 20:/PC)A,],%BX0&=IB%B7W7W1AU KLU!D8BX]$B_&^Z+U%L[9*N' M8\242U(>#A\D?!1OPLB_EZ_+#+NUWR!U!:2\!TL)+Y0,2P2N#,PN-%W<=0;9 M #0;-A3JON>8K#^!PO#M.!1PBM*<,#W$V2,<'N:.SWZ'OTW,*#D $50]C?0\ MST2CPQ!F\%%F*S0%$!2V@G?'!R&B;ZV'G9Q>L>NS_X/1;ZS8=HGE[?ZR0_^& MXC<,OHX:%S>-JS<2U4J^U$#=@8ZW>AX$MRC?KB,X5:!F%\Z,:OTIW1+6$4XP ML*B"U$ .#,?LC989D6=&%"8C,OA&=<:#S M&%4>P%[=H8C+ZL[&A@9Q%W4:5R,X__UJ ]XL%H8::-R3GB4R+6UF6RJS.FCQ MZ8!-I!1I-MFG+51_07U!9LA:(/PI\&S.Z>/V[L6J%^!I$)IJP9%?F;,)O0S' M]63$'K_+!6SB7C0'6U*ZX?N"*Z0A!<[UA1_CV;M8T"-/3SZP0[OA'GT_/Q.* M#_6XKX_P\$D;^Z6#4I.ZZ>MAIF>&['AP,JT8C7?V7!5@2XXQ[HF,<:\$X]*Q M=C!0( L!5!@9$C([ 3-"">*5'+)4&*5SQ*%@L*943?HPIR]H$??I;;@B)4V MID0;UH(&J@>)O#3H2@>[T4%V(;:2.0F.HQ%QOQ:^J T%-,T]S3A'7N8A*,8] MW70,J%+>P*Z<(3?RHW9 N%<&8G9X?6RES$XF@@C686#HCZR[BT&)U$18TG"_ M WW&;D5XUQ[&]0,T)^2?@&)*%JO\4^GC@3#_#+>Y!'CEGQK!,-0H42G_C,.W M'=F#KLQCE')($YI_*(&]<*5'_VRGQSHH[70DN4L#84GKIQ-]NK0(G)8'?VF[ MGUDZ,B5,7A@-;!X&OA&K3A2318_,,[34<02"62#&8\\%B8NG+(;4QW,1B&TT M[N J NCM+L?03:4Q]8#!E-EEG( J90()Z FZR5D*6,M#*AG0ZQ0*VUA2# %D/ M!0G#N3$ />&LBVU@;<5>%Z )MW= MX?/ADT2JOL-#2NW#N-"E^4XPD\Z@-Q(WWP4(DZL <(&VS9VMSSMI7,7,CAY\ MSLE]^N!#SW2O'TGN !AU1 (>%'5'[V;0'FCCM;V@B4)X5.9E1;CT6YZV%V"0 M> Q2%)'[572;*%12"XA6L]!RXH&0A;TNC0@T4@"F/,(TE,K(&V:1%U1(@BPL0\GLA#T)?(AX%-5\9P@XRI9CU!UC]W,%3-/5OXM^ MX/6S,,4CK.\"S')G" (8'*-[UA+@T7'96 2 ;X;P95 #:A+F314X?>E"GP\ M%'.OQ&C[>/J%-B;\^CH\ S9/X_H+V@RB:"GZ%Q:]R$"1L8E(YR[[7-N>M4$L M"8*@M'&#V"54%A,J'DA#+R\B!Y9]9'E7YE.>6O6,#X(8CVX)>)GG"6!G:"C4 MYY D( 9>\D5T%ZA;*Z"-_P(#*6V-"'R5@40V@MWQN.PN&=F"HE,[U_T0[727 M&('"R)=,AN0H2"O G-P^ M]"6X%@]*E8XY]P9&7&)PKL^7#&DQ,3-TYM05I9)X:%LT MQWAK3:" DU2'Z8N\3P$8$?FYDI@E;&=\GD&QH.'GH/,4HTP%B%*5^Z*XER$! MUX26+C&ZF!A%>6==LQBPIN*>#5//J?_D%"8G+)T/],L\U)J?AK##(WB@@EX' M4*S#+LAE3PZT.Z[(6B.4"H"7=N$ FV*;W%T*)5 *H \5^@17\)Z,6$][#=SQ5^Q3B(+X2-, M+O/;H!E*"RGGEK8)?P6 M%WY*&%.QJ="722, -NAT_, +VLC96HK;-#6Q!,QB B;O>P,I%IOPMM2WICT. M%*PJ^]P9F$!6XSX+5-9[9B,!$_F)BX2)J[XU/FO'!XAPS+"%%DVXBA>$NC'- M^6*?QU$'!/;?(/LI*DQ15#N\9FR$3N"W2#)3P$P*\260%Q/(%&)HX@8]V94V M^M,PP=QQB&J4 J),D"-^/N3)2]3/;N *;XFIQ<04'@_"&+.:,7HX+QB$E2.SF'*!P-5&>,O)!H91 LXOZZ6(02WA Y&R@\, 8'+$JEOS$4LFOEJ=1:N.IAAL)2XUI< M]&H9YP2J%QCG(R7O:IT+L&23=X_X &];.0L]#)+4&5!+Q"PB8G0N.[(KP?J4 M1T#6HE0\YO*ST=5'6?H8)$MX:ZM2F28I;848/&E#E8H2H.YH2F=/A^6 M)\;U/'W&M+F*QM0YL 7$\JQ])!UW2NKSY!S;.=*K0Q%AKJR*.E9=-;'UMEY6 MW?>QXRN!&<-HQCO!4ENSJY]75O^3W$B5W&T38G4'*O5(Q2'8L7#HB*4QN%&E M:\@V2O"F9T-LANI-(*F2FA-'>.F1*; " Q--A84;=6/537VG63:&(F$_Q4)' M$$QL6O\5J&'L1"^'2:;'GO2'7Y,#GR7*<5K9!5^KPV(.0DD,+2U!'KM-"Z*DT2JXG&6P(S@2W"VHNF MOH112"ALRK.IZ:&-[,1KN])]H,LDD-48'1BVPDZF+$3:1Y(\3QFU").DSBB> M[9^Q7%B6CAJ$.:JY9B29.B_ N/@MT! #QA)QB&O/=$ABF?T!?P=X"-#@C?BM MT/4*FIYL)Q4%XQY]":N4V*;Q)2QK&MI*@E,K#S!]Y9O2NYSJAO9U]0U@E%(Y M<1=7F=(96I$1X9EQ)E^G$@^Z6JFC8>:0-27VTV(5;A(<(NX= =*"(T'^BJ72 M!VA0#9)R%CZZ+1Q_!WTL?HNNVH<75X< MG9V?U6_.+B_8Y9&OWW5V48E]69!U'NDQYBR) [>59ADFQ4+2=VQ4JZ0&%V( MF*NIG.$P/#\YNKXS4\4C*7EF2[;,(6I=T4*GG+XX @%,X/Q9,="55QPHLB.SBA MI*9PKI:PF%C/>=+[KFQ3M:9,H$?/?J>-X]8U4.Y1&XUEV+%7G]H;&HN%_P"G MXG3L!A4M\DR9*!AB*U:D_";5[(QX&RIJUP09"WQT&-P:O(RJAX9:GQAZPY58 M.52'^HF(A7@7SW,)S52S2LKA8;$>P"(MR%PKFH75&&ACV6>!$^9$*:#1GZ!J M$XF&[X2UVMWPOBQ-WY@LLR\=[B>U5W51/EW>P[+E;! 0E9+U85#[HNHXM%]E0,@ROYE2A/IR6E230@N?,9,96YO9F([ZPK*B[&>)8C?" MG[3^G)DNK(F'!0@#:XC*9%5@<78T-ND-1HO:Q[+JA/QD3L6"^14IB56(D:,! M>6U- YV$D=9"&YH')51BG(%/N9&&*0#/4FVK/79',695JJR^,IYLJ#OITUE2 M=2SY)']9ZK-5V+H9'1QQX/1H8=%)?V-I^HCE3G0192@30R#/U@A+&! UFB); MY!+H;BJ(8?Z+C)#3F"U%]29U02;D1+8P,\H,"V(3$9P\MWTD&PEA;H87\BX6 MO?=]#.(-(':X)[)QNB;U#+D9,;X M.>=>?HGUU//#25F>P%@NQ MW\/(6$>C)L @,*P)[V<20^T^PVL59 L.E7B7+F[S4B)(4TMS*B,#K-KL W:1 MI9+359_LVG!*2 S*2)8VU;[$-,$@- 7^X4U?#+'MM%*3$D:A0!Z$HEJG'=(% MQ@[>-1XE=!6/KK>:%BE+F%7LI^7ID/'!K@OIS*8KW]$H@>DE"8J:18?"4DO? M2(#'5I@<\''BCU2KUHCG3(':80E?,O:A#D-+O3]K8_I/=+[4QY:[@/-W/&R5,33=!PA7>C3<.#HA+^ZUE6,1[7F8T\YO*W M[7E1.@F'V1EG&DVH.N'R\/PK0V.8,/F7O%SW85MXE#@?\=(/?1E2^&D**N9& M3Q:F0[SXJ67A9$U=.)_&(/6AN MU[_?8D_.P>3$R^[V'7FABKIRA4TFY@J]-$ 1YZB> K(V(\I<:PG3:OY14 MKVX]AUC'5F?)]:%W?E*PIQ=*.XZ _FS7RC]8&J]YCVQ%\EI]+'7PIH+1D=> MUS>LFQ^_SOZ&Y9$$7Q! .^6->;IYA R:T-3#QUC=7"^OIQ/%"W?G:..YMO,2 MS^13Q?I.861-C&3G?6IHS_GB$%HV=LJ;+XOH1PZT6MLL;[X^K)>,>\:5R<:: M_O@;O9\8-N7M=P'OK4IY^_71O<1RBN5CD;D-ETSA78S*U?=:OPUPKW\N;[T+ M=%>K&W2E_=N ]_)XN8#'RZ7@GL;LM'?O;7"UG>UR]5UP->)DM;VQ/S8_5\J? MWPS'6V(7\>KA'^5+WCZ5MX^)_1T? M)TP7@">Q1FG3DZ\ +[%U?0OXV]@SA,&=\1S9_ "=^85->(^<2VUS:<9[6QOI M>&*PO)$;[WW[;)1K[V)K;*R7JZ^_-9929]IF^8*!MR!:QN>.O/NM\CZTLX^P M8)^6TN--;(AQB5++;? BVV"[O/7ZXF)I?%P:'Y>JPAR)S6\LYJ.ZOEW>>>M! M'[7/E26/>UD>MX$,YIZY08Q)5:_#Y!XTAC>N[3U9OLGAYRAO);C8;5F=CTBV9^N8&G1":),E2,FA 18^0 M(%@3!V]<4"(R6:-E=M,QB;64:6^R0XL%G5*HJPTU170GA,[_3!-_J;#>0VLJ MV.1_+#T4ZJL4,6DZ]B.37'ZO2T*2&4*7A#3F<)PM_/8Q_&3*,_7H+L6 T5T4 MZ7"30KGI==KXW3]C)4-75]B%-LK_Q)J ,Y"]_M:0W4BJL< "?339W)_6#'JI M/ FEQ(:[$U:K^#0IKI3UFU?54AS,F?6ZL_/D2:_++-=Y9>186"/=SZ:-S9/4-?\[KV+<>R]1)&_+ M?O=QJUSY-$\_KVF_^UBME+?F]]2]L+_M;4==O E'V,=*>?V%4?;8D:X_!=(6 M@^G-"&)X$\B;%NQF?JP^:KE?"9]SS&?\[-(?&7FQY*4S8Q#>!(K?%40_5LO5 M)Q/6R]/""YX6%D-LW02ZAF]BS,^8W-^>=O[2>M-CM//-\L:B;?CWYM^>XIK4 MQ4+'.BC7-__A12MKU4>:\^WCS>T/6:/'='/7J.EEI%3.J/?^\U9S:UI]0/WY MB/,^P\SU.^-X0&88&4OGBW@1LO%8=O &4QN(_1>@AW:BVJN3%R!]=#V0U)O,>9YFH/Q,=(=\?5,"5Q>OM?CB!4VZ,4M?%:BO M&XE]G)E+)490\N3KV%#29X?<'_!G6J-AH)SB-1Y!BR53O#+W M1+PT1@3,O,F?!R/5H5B'IQ,@Q7%199G!5+G[P_U!+ P04 " !..718$A.[+T # !-"P $ &AL M9BTR,#(T,#,Q-RYXE$-''L_?O3KZ+8[BXO+J!&);.-;9@[/[^/JGF0EDM M6T<,-BEUS2".!_]?;[_"'QU[ 5.4R"U"S:U# [^T0E9%GN:3+,WR)!_##'+/ M!Q5W6,"$Y2E]\I\@RXK\J$@_P/EG^!1H%-R*&L=8W:R,6"P=?%_^ %UH95" M*7$%ET)Q50HNXX4F4"YU+"U,,LZ;1H[K!*>M8'6Q6V7&+-W[\#H(0I M6RBB;.O3R&>B3\3#S,A$FP6KG&%NU2 CIYB\T(@R&D'_'?<$0Y7P%KL&SKF= M!=!@\?F9C!!+.=\X98EFQJ688RB13TLZR3Z, !6*-2!(LE@F"WW'R+!-[NWB M^2#R-)TPZ@A'><811 KUUQZ$-\^H.<:'/('<3P(@.SX^9L&Z):ERFQ'T[$>L M,P9O[IP1L];AI3;U!3+"&R"-2SLG?4$-B;A0S5?960=6L<+,3N:F&_B/UBU^G/-_ZK,[!]HWW\ MQS[^[.>#XG\R$?X#)5K=O%7,:*R]OB:*B[*;6MWR\+H\(M_4F\-8\'DXVGOP M]ASI3PUG-E?"F$6JN^RW:]$U<#)T\Q3F$^55P4QHMN$\^!K;P9O MI]>2RS6U[X;3R%+:Y>AV_K_1-@9?&BU!+ WW4+3=0?\^\GIQ[/Z<6_( O_@Z MO=KS/*S?!^;X@U:Z7G4J+W39^C=H^'^NJD^*M*VNJ+%,'71%(.@AF9+[MX/< MURH'G172KS<1NC=+_1_]N!L8QDNN*NCH8,1WPK9)MOE;B]5OZBRL2R[+5JZS MWH-[CWW [7H=CGQ4MAO7[PX5&VXQV[[&_<[XNG=;W;BAK_\ 4$L#!!0 ( M $XY=%BEP.#'O08 -%) 4 :&QF+3(P,C0P,S$W7VQA8BYX;6S-G&UO MVS80Q]\7Z'>X>6\V(+)C9\-0HVF1.YI!PCSN$_9_+RS MBAPW\BCM0!2[S'<#SLAY9T.BSLD]/3UU_ M1EG$@U4L):.NQ\,>.$X>/YI\AC_2G@K'_: M'W0'Q31!7*4'OAN3(9SU!J?RU^ GZ/>'@Y^'I[_ Q2>X2F083&A(BKE\N1%T MOHCA!^]'2+(N.6,D",@&KBESF4?= !YSRR=PP[PN7 0!/*BT2/J,B/A*_&ZF M&E#VWU#],57NX>T; 'D;692<.^^HFY'=B_54!%TNYM+LZ5DO3^F\9*SW4I[. MDH3^NW?O>LG58G1$=;%2O-_[Z]/XT5N0T'7D[9=?+B\K$]%AE)P?DHK"ZG%3O9/'Q M9BGCR3HFS">9\K,V][*HA2"S5%7!ETA&Q.O.^=>>3Z@BY$P=..I .?Q>_N/+ MB$O>+Z91+%POWJX7J%O$17XR:>*\HTGJ;1M2<1?"V])RA9?KR,,#_6<1/8_+ MK]LR=A+%/'TF>*AUD97CFHM?@FF@M:E(DD=J>!/F?'X\U&LJ5&Q,D(BOA,2K MSI=#H@S_Y-K_ON^]U'XM5N44$I%Q7;]V2%Z$$G/Y.[X.W+DIDCM)+2&I MM\XU%VV0U @A(?FL#$K:&L@&C!:!-'5KA^,5BVF\&$60#:X5@DC8IA4@*P%)#9!%K %NT'H1Y/K^[9"^Y-Y*C9N)=&]* M\G9.2P!KC?/]:S:X[NL@49H+@U*V1A/?9I%(0Z\X&-X30;E_Q?Q+^7FF+H\[ MR2V#J6^%5P1AH*H1Q&8V+0&R!J@B:/@V8%W+L;%_C,7" YE3M4AF\:T;&A.M MSVUUJ5#2""^/L5\HZ/1PUPDO%4"50%HE-.%;LT@P-H\!\@WSN%ARD6R5/,9R MX(SX2BY2-B/NU^3Z@%2KF)NUR8U3[ >!@3SNF-@J"$E%R$J"JHDT2+Y!7YHQ M_%TM7,J5.J3R2$!C^]70:V0: M ]2)N[[QY6*)SFBZ.7X,M:4BK2)\J#5N$&P/=Z4P+NFR%&S7PN6^T58T@^"( M?C"&Q(7ORP:B[*\Q9:1?;SAH!5H="E4M\0.!]D.@5!07_TS_)#\ 50GN&-8Z MIK$V-.@?T0LB^B-Y>"@"N'" MCMU %>IF72!BKCY6\^,0SU-? ]X[;>C03D/0L"[*-81T6@(79DS;52 ?\HXY M4Z>?:(^;IO/19&=-XY91\R#TBRO<\BMW@ M;[JLO\^H5W@-6.N;TL&]%8F&N$:U(=#32B!+8>X=-M=&%?;&O>#LM\^X")./ MM]?R@(@QF;O!G4@W_8D@?OT'2J::+>_ UVJ]!VSEMO1BK,\[WKUF]%KNG@X1\ M\LE/*>-\Z\#WN?5*K*%9.Q#5N^K!_8*SFH^1]O-: K*T :Z_;@.F7@L)SD0< M$G6L[?1F_!8AK6/:#M0_!8UCPD8\#%I6>$60#;P5@D@$ M9Q5@NX0UQ0T:+Z)%F&#<)D: M$K\O\I#K6\/;E.4BN;5\VV%[+X@:'T1BD;P@K/[3F+B;S4.\E5Q/;?J#Z83&@?$>QWY>6TN; ML@:X_KK5LD:KA;6HR<1!JD,B;[^F:<3OUHJFAFD[4"?"53^"X7$33KGQ$GPG MJ25$]=:YYJ(-G!HA)#(S94BEK:ELP&@125.W.//FU=I;R&Y)G4W=?#GDOS"CA/19KSK9U3#J-9E@/&[7&ODP!-?%(3%-HD6;0J.-_XX*$8:MQV:I?DQKY6*CV&R>DA^B'TFFNI-" .>P(3TFJ(@8Y61D+?]$^B*JD0[G9&AD M&GUJ4"\0UW91.1-_M\S+Q+@G[]\1_,-$"IV5MCV3CETVUA/%:U+-T&Z]&5B1 MMZ]9'XE6S4P27E]?!]G9?'W-BFIC V'PY\-@%,TAH3Y"0&C105/H)DZ_J/?- M70;;D[:^9BV=11K(*,M]B6Z1DS7,)]]6\TV1'S;\9EA;Z]B[-4UNLZHDAR%, MB7G_-.SGVIR#FE#.II -JHQ_O1E>!2E=2R&336!$P9V,E@F(U+YW1'PO4I9N M^F(J59)UQ2-95EMS!5-L@D]]&\SX^7Z(<3Z?$R?=+/#"T"Q9?A<*Q M(]*L]@ +<@)8IR!BB&T8X_^_ZO'M%NMN[,HHGX'=Y9LQTQ#59O(EB(&9%IOF MP.2GF>4&/WSN2IPQ.A.=*AJE^1QP,UBDLH6<3H"WO0)1\"T-=;#;L>EZC]-9 M64,'HKRA?6X=%>5"4A79<'AX!"T_\'&K*: MWQC/=C1VL0>*\CZ.^/5OL"F+Z82XNKA.&+;8FLY@L_/)&--8EE9>4UU(>9^6 MS:5S;)X!O>)T']_AC=&YD [$U:=U8-AB^]D9;-NY80@S9CHJTD>:E*96K*TN MM&*_EMF58\QP32#50JHLM2/,,'3E$J?X35?&9R+\2JBJ$_V*?0OX%\< ]QB' MQV4R 74>S7U=U='M>[6^!=K)(%4G>-+X#F>S[AC. M3AQCDO7N#9?($)Z'LC! U3$6FK8(0S<1=O'P28WE2KP)X+[<$7S[EBT\UU;E MNZZ8V[3#_:R2X*S4$6C6K@7FSGH\/_:V]UQON]2LUA%D7_Q:9A=N,GN6.J7\ M+[8X?\U0',$1?@>N+45W=EN.MM-[> !J #/*G]1VB0OH\OSE?-F852==MA^6 MO3M;-N9+OJ. GG/-YC7599?W:=FXLS5C?IKDSW,ISERY'^NJR^C8J^7DS@[+ M'^@O!=&52;(4NX6K+@OKA+BZQ$X8MMCZ#8"#/6RC$K4E87 M6)';':T+=_93GA68(0;M&?-BGLS% MDG\ 4$L! A0#% @ 3CET6!BY0RIZ$@ 4&P X ( ! M &0X,#DU-#!D.&LN:'1M4$L! A0#% @ 3CET6&'QDQ:='@ -M\ M !$ ( !IA( &0X,#DU-#!D97@Y.3$N:'1M4$L! A0#% M @ 3CET6!(3NR] P 30L ! ( ! XML 17 d809540d8k_htm.xml IDEA: XBRL DOCUMENT 0001180262 2024-03-17 2024-03-17 false 0001180262 8-K 2024-03-17 Herbalife Ltd. E9 1-32381 98-0377871 P.O. Box 309 Ugland House Grand Cayman KY KY1-1104 c/o (213) 745-0500 c/o (213) 745-0500 false false false false Common Shares, par value $0.0005 per share HLF NYSE false